- Home
- MBC vs EVO Comparison
MBC vs EVO Comparison
Compare MBC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBC
- EVO
- Stock Information
- Founded
- MBC 1954
- EVO 1993
- Country
- MBC United States
- EVO Germany
- Employees
- MBC N/A
- EVO N/A
- Industry
- MBC Agricultural Chemicals
- EVO Biotechnology: Pharmaceutical Preparations
- Sector
- MBC Industrials
- EVO Health Care
- Exchange
- MBC Nasdaq
- EVO Nasdaq
- Market Cap
- MBC 1.8B
- EVO 1.6B
- IPO Year
- MBC N/A
- EVO 2021
- Fundamental
- Price
- MBC $11.84
- EVO $4.21
- Analyst Decision
- MBC Strong Buy
- EVO Buy
- Analyst Count
- MBC 1
- EVO 2
- Target Price
- MBC $19.00
- EVO $5.90
- AVG Volume (30 Days)
- MBC 954.8K
- EVO 95.3K
- Earning Date
- MBC 05-06-2025
- EVO 04-17-2025
- Dividend Yield
- MBC N/A
- EVO N/A
- EPS Growth
- MBC N/A
- EVO N/A
- EPS
- MBC 0.96
- EVO N/A
- Revenue
- MBC $2,700,400,000.00
- EVO $825,103,013.00
- Revenue This Year
- MBC $5.06
- EVO $12.17
- Revenue Next Year
- MBC $5.11
- EVO $14.32
- P/E Ratio
- MBC $12.35
- EVO N/A
- Revenue Growth
- MBC N/A
- EVO 1.99
- 52 Week Low
- MBC $10.84
- EVO $2.84
- 52 Week High
- MBC $20.67
- EVO $5.68
- Technical
- Relative Strength Index (RSI)
- MBC 44.34
- EVO 69.78
- Support Level
- MBC $10.88
- EVO $3.47
- Resistance Level
- MBC $11.97
- EVO $3.74
- Average True Range (ATR)
- MBC 0.72
- EVO 0.16
- MACD
- MBC 0.04
- EVO 0.14
- Stochastic Oscillator
- MBC 52.91
- EVO 99.28
About MBC MasterBrand Inc.
MasterBrand Inc operates as a residential cabinet manufacturer in North America. It offers a comprehensive portfolio of residential cabinetry products for the kitchen, bathroom, and other parts of the home. The firm sells its products throughout the United States and Canada through three primary channels: dealers, retailers and builders.
About EVO Evotec SE
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.